Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Anticancer Research|September 12, 2013
Phosphorylated S6 kinase-1: a breast cancer marker predicting resistance to neoadjuvant chemotherapyEun-Kyu Kim, Ji Hyun Kim, Hyun-Ah Kim, et al.
Journal of Pathology and Translational Medicine|January 30, 2018
Cytological Features That Differentiate Follicular Neoplasm from Mimicking LesionsKanghee Han, Hwa-Jeong Ha, Joon Seog Kong, et al.
Skeletal Radiology|September 3, 2013
Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcomaByung Hyun Byun, Chang-Bae Kong, Ilhan Lim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2013
¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcomaChang-Bae Kong, Byung Hyun Byun, Ilhan Lim, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2007
Clinical significance of (18)F-FDG uptake by N2 lymph nodes in patients with resected stage IIIA N2 non-small-cell lung cancer: a retrospective studyIm Il Na, Gi Jeong Cheon, Du Hwan Choe, et al.
European Radiology|February 15, 2015
Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CTByung Hyun Byun, Sung Hoon Kim, Sang Moo Lim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 22, 2014
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRIByung Hyun Byun, Chang-Bae Kong, Ilhan Lim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRIGi Jeong Cheon, Min Suk Kim, Jun Ah Lee, et al.
Pediatric Blood & Cancer|March 4, 2011
RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcomaJun Ah Lee, Jun Soo Jung, Dong Ho Kim, et al.
Pageof 10